Perfusion Disposables Market Size, Share and Trends 2025 to 2034

Perfusion Disposables Market Size and Forecast 2025 to 2034

The global perfusion disposables market size accounted for USD 2.87 billion in 2024 and is predicted to increase from USD 3.11 billion in 2025 to approximately USD 6.37 billion by 2034, expanding at a CAGR of 8.30% from 2025 to 2034. The prefusion disposal market is witnessing significant growth due to the increasing demand for advanced medical research tools in drug development, organ transplantation, and regenerative medicine. These disposable components, including tubing sets, oxygenators, and reservoirs, play a crucial role in maintaining sterile and efficient and perfusion systems.

Perfusion Disposables Market Key Takeaways

• North America led perfusion disposable market by holding the largest share in 2024.
• Asia pacific is estimated to expand the fastest CAGR between 2025 and 2034.
• By product type insight, oxygenators segment system held the largest market share in 2024.
• By product type insight, cannulas are anticipated to grow at a remarkable CAGR during its forecast period.
• By application type insight, cardiac surgery segment led the global in 2024.
• By application type insight, ECMO therapy is anticipated to grow at a remarkable CAGR during its forecast period.
• By end-user type insight, hospital contributed the major market share in 2024.
• By end-user type insight, ambulatory surgical centers are anticipated to grow at a remarkable CAGR during its forecast period.

How AI is transforming the Perfusion disposable market? 

Artificial intelligence is revolutionizing the prefusion disposables market by enhancing efficiency, sterility, and precision in organ preservation, drug testing, and biomedical research. AI-powered systems are optimizing real-time monitoring of perfusion parameters, ensuring consistent flow rates, pressure levels, and oxygenation in disposable perfusion setups. Additionally, machine learning algorithms are improving the predictive analytics of organ viability, reducing waste, and enhancing the overall success rate of transplantation and research studies.

Additionally, AI-driven automation in manufacturing is also streamlining the production and quality control of disposable perfusion components, ensuring higher sterility and compliance with regulatory standards. This technology is particularly beneficial in reducing human error, improving workflow efficiency, and enhancing the traceability of perfusion disposables used in clinical and preclinical

• In March 2025, a leading medical technology company launched an AI-integrated perfusion monitoring system, improving real-time control of disposable components to enhance organ preservation.

Market Overview

The perfusion disposables market is experiencing steady growth due to the rising demand for efficient organ preservation, biomedical research, and advanced drug testing methodologies. The increasing prevalence of chronic diseases, organ transplantation procedures, and advancements in perfusion technology are driving the adoption of high-quality disposable perfusion components in both clinical and preclinical applications. Additionally, AI integration and automation are enhancing real-time monitoring, sterility, and efficiency in perfusion systems, further fueling market expansion.

With a strong presence in North America, Europe, and the Asia-Pacific region, key market players are investing in technological innovations, regulatory compliance, and supply chain optimization. The market is witnessing increased collaborations between biotech firms, research institutions, and healthcare organizations to improve disposable perfusion system performance and accessibility.

Top 5 countries in Disposable Perfusion Products

Top 5 Perfusion Products Launched Around the Globe

Perfusion Disposables Market Growth Factors 

• Increasing Organ Transplants: The growing number of organ failure cases and transplants is driving the need for high-quality disposable perfusion systems to ensure organ viability.
• Technological Advancements: Innovations in AI, automation, and real-time monitoring are enhancing efficiency, precision, and sterility in perfusion setups.
• Rising Biomedical Research: Expanding research in drug testing, tissue engineering, and cell therapy is increasing demand for single-use perfusion components.
• Stringent Regulatory Compliance: Strict health and safety standards are pushing manufacturers to develop highly sterile and efficient disposable systems.
• Sustainability Initiatives: The shift towards eco-friendly and biodegradable disposables is gaining traction, reducing environmental impact.

Market Scope

Market Dynamics

Drivers

Rising demand for organ transplantation and biomedical research

The rising demand for organ transplantation and biomedical research is a crucial factor propelling the perfusion disposables market forward. As cases of organ failure, cardiovascular diseases, and chronic conditions continue to surge globally, there is an increasing reliance on advanced perfusion technologies to enhance organ preservation and transplantation success rates. Additionally, biomedical research, including drug development and regenerative medicine, heavily depends on high-precision disposable perfusion components to maintain sterility and efficiency. The integration of real-time AI monitoring and automation is further streamlining perfusion processes, ensuring enhanced accuracy, reduced contamination risks, and improved outcomes.

• In March 2025 leading healthcare companies, including Medtronic and Getinge AB, announced strategic partnerships to develop biodegradable perfusion disposables, focusing on reducing the environmental footprint of medical waste.

Restraint

High cost of advanced disposable perfusion systems

One major challenge affecting market growth is the high cost of advanced disposable perfusion systems. The development and manufacturing of high-quality, sterile, and AI-integrated disposable components require significant investments in biocompatible materials, regulatory approvals, and R&D innovations. 

Many healthcare institutions, particularly in developing regions, struggle with the financial burden of adopting such advanced technologies. Additionally, concerns regarding the environmental impact of disposable medical waste are prompting regulatory bodies to impose stricter guidelines on the disposal and sustainability of single-use perfusion products, further complicating market expansion.

• On February 2025 the FDA and European Medicines Agency (EMA) introduced new guidelines for sterile disposable perfusion systems, emphasizing improved safety, traceability, and quality control in organ preservation.

Opportunity 

Growing emphasis on sustainable and biodegradable disposable perfusion solutions

The growing emphasis on sustainable and biodegradable disposable perfusion solutions presents a significant opportunity for market players. With increasing awareness of environmental concerns and medical waste management, companies are exploring eco-friendly materials and biodegradable alternatives to conventional plastic-based perfusion disposables. 

This shift not only addresses regulatory compliance but also attracts healthcare institutions looking to align with green initiatives. Additionally, advancements in nanotechnology and AI-driven perfusion optimization are paving the way for next-generation disposable systems that offer both efficiency and environmental sustainability, creating new growth avenues for the industry.

• In January 2025 research institutions in Japan and Germany unveiled AI-powered predictive analytics models to optimize perfusion processes, enhancing real-time monitoring and organ viability.

Product Type Insights

The oxygenators segment dominated perfusion disposables market, due to their crucial role in maintaining oxygen supply during cardiac and ECMO procedures. The development of next-generation oxygenators with improved efficiency, safety features, and biocompatibility is driving growth in this segment. The growing adoption of minimally invasive heart surgeries and heart-lung machines in various healthcare settings also supports the oxygenators segment's market share.

On the other hand, Cannulas is fastest growing segment in Perfusion disposables market, due their demand surges with the rising number of minimally invasive cardiac interventions and advancements in biocompatible materials that enhance patient outcomes.

• In March 2025 a global medical device leader announced the launch of an AI-powered smart oxygenator, enhancing oxygen delivery precision in cardiac procedures.

Application Type Insights

Cardiac surgery dominated the perfusion disposables market in 2024, due to its increasing prevalence of cardiovascular diseases and the adoption of advanced surgical procedures. The rising integration of advanced technologies for perfusion products, especially in well-developed areas, is seen to promote the growth the segment. Innovations in cardiac surgery technologies, such as minimally invasive procedures, robotic-assisted surgeries, and enhanced perfusion techniques, have led to a higher demand for specialized perfusion disposables, including oxygenators, blood filters, and cannulas.

Meanwhile, ECMO therapy is the fastest-growing segment, largely due to its expanding role in critical care for respiratory and cardiac failure, especially during pandemics and post-operative recovery.

• In February 2025 the European regulatory bodies introduced new sterilization standards for disposable perfusion tubing packs, improving patient safety.

End-User Type Insights

Hospitals segment dominated the perfusion disposables market in 2024, benefiting from high patient inflow, superior infrastructure, and government funding for advanced medical procedures. The availability of experts/professionals at hospitals setting has promoted the growth of the segment. 
However, ambulatory surgical centers are witnessing the fastest growth, as minimally invasive procedures gain traction, reducing hospital stays and offering cost-effective treatment solutions.

• In January 2025 the adoption of 3D-printed biocompatible cannulas increased, particularly in the Asia-Pacific region, to enhance patient-specific cardiovascular surgeries.

Regional Insights

North America remains the leading region in the perfusion disposables market, driven by high healthcare expenditures, strong regulatory frameworks, and continuous innovation in cardiovascular treatments. The growing adoption of extracorporeal membrane oxygenation (ECMO) therapy, particularly in critical care units, has significantly contributed to market expansion.

The United States dominates the North American market, primarily due to the high prevalence of cardiovascular diseases (CVDs), advanced medical infrastructure, and rising investments in organ transplant and cardiac surgeries. Major industry players are actively introducing next-generation perfusion disposables, including AI-integrated oxygenators and bioengineered cannulas, enhancing procedural efficiency.

• In February 2025 the FDA approved a novel AI-powered perfusion monitoring system, designed to optimize oxygenation and blood circulation in ECMO procedures.

Asia-Pacific is the fastest-growing region in the perfusion disposables market, driven by rising healthcare investments, increasing awareness of cardiac treatments, and advancements in ECMO therapy. The region is also experiencing a surge in cardiovascular surgeries due to urbanization, changing lifestyles, and a growing ageing population.

India is emerging as a key market in Asia-Pacific, with increased government initiatives to expand cardiac care infrastructure and a growing number of private hospitals adopting advanced perfusion technology. The demand for affordable yet high-quality perfusion disposables is rising, leading to strategic collaborations with international medical device companies.

• Indian researchers developed cost-effective, single-use oxygenators, aiming to reduce dependency on imports and improve affordability in cardiac care.

Europe represents a developing market, with a focus on regulatory compliance, increased adoption of minimally invasive cardiac surgeries, and advancements in disposable perfusion devices. The region is witnessing a steady increase in organ transplant procedures, further driving the demand for high-quality perfusion systems.

The United Kingdom is a key player in the European market, with significant government initiatives promoting advanced cardiac care and perfusion technology integration in public hospitals. The NHS has been actively adopting ECMO therapy and innovative perfusion solutions to enhance patient survival rates.

• In January 2025 a leading U.K.-based healthcare company launched next-generation cannulas with enhanced biocompatibility, reducing infection risks and improving surgical outcomes.

Perfusion Disposables Market Companies

• Medtronic
• Terumo Corporation
• Sorin Group
• Getinge AB
• Livanova PLC
• Abbott Laboratories
• Nipro Corporation
• Xenios AG
• Eurosets S.r.l.
• CytoSorbents Corporation
• Repligen Corporation
• Merck KGaA
• Fresenius Medical Care AG & Co. KGaA
• Baxter International Inc.
• B. Braun Melsungen AG
• Smiths Medical
• Stryker Corporation
• Zimmer Biomet Holdings, Inc.
• CardioQuip LLC
• Medivators Inc.

Recent Developments

• Medford, Mass a public benefit corporation transforming global access to protein manufacturing capacity for diverse applications, announced today its first distribution agreement with PharmNXT Biotech, an Indian bioprocessing company. Through this agreement, Sunflower will commercially launch its Daisy Petal™ Perfusion Bioreactor System in Asia, a significant step in the company’s ongoing product commercialization.
• On 31st March 2025, Scott Attorneys at Law LLP a shareholder and consumer rights litigation firm, alerts investors that a securities class action lawsuit has been filed in the United States District Court for the District of Massachusetts against TransMedics Group, Inc.
• A Japanese medical device giant introduced AI-driven perfusion monitoring systems in India and Southeast Asia, enhancing precision in cardiac surgeries and ECMO therapy.
• The European Medicines Agency (EMA) introduced stricter sterilization guidelines for perfusion disposables, aiming to enhance patient safety and product efficacy.

Segments covered in report

By Product Type 

• Oxygenators
• Tubing Packs
• Cannulas
• Reservoirs
• Others

By Application Type 

• Cardiac Surgery
• ECMO Therapy
• Others

By End-User Type 

• Hospitals
• Ambulatory Surgical Centers
• Specialty Clinics

By Geography

• North America 
• Latin America 
• Asia-pacific 
• Europe 
• Middle East and Africa